The corticotrophin-releasing factor-binding protein: An act of several parts

Peptides

Volumn 19, Issue 6, 1998, Pages 1119-1128

  Kemp, C F ^a   Woods, R J ^a   Lowry, P J ^a  

^a UNIVERSITY OF READING   (United Kingdom)

Author keywords

Corticotrophin releasing factor binding protein; CRF BP; CRF like peptides; CRH BP; IGF BP; Post translational modification; Proteolytic cleavage; Regulation of hormone action

Indexed keywords

CORTICOTROPIN RELEASING FACTOR;

CONFORMATIONAL TRANSITION; HORMONAL REGULATION; HORMONE BINDING; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN DETERMINATION; PROTEIN PROCESSING; REVIEW;

EID: 0031870922     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-9781(98)00057-6     Document Type: Review

References (109)

1. Baigent, S.; Corder, R.; Gaillard, R.; Kemp, C. F.; Woods, R. J.; Lowry, P. J. Further characterisation of novel ligands for hCRF-binding protein in sheep brain and a human tumor. J. Endocrinology. 144(Suppl): OC24; 1995.
2. Baigent, S.; Woods, R. J.; Kemp, C. F.; Lowry, P. J. Characterisation of a novel ligand for the corticotrophin releasing factor binding protein in sheep brain. J. Physiol. 489:P183; 1995.
3. Bauman, G.; Amburn, K.; Buchanan, T. A. The effect of circulating hormone binding protein on metabolic clearance, distribution and degradation of human growth hormone. J. Clin. Endocrinol. Metab. 64:657-660; 1987.
4. Behan, D. P.; De Souza, E. B.; Lowry, P. J.; Potter, E.; Sawchenko, P.; Vale, W. Corticotrophin releasing factor (CRF) binding protein: a novel regulator of CRF and related peptides. Front Neuroendocrinol. 16:362-382; 1995.
5. Behan, D. P.; De Souza, E. B.; Potter, E.; Sawchenko, P.; Lowry, P. J.; Vale W. W. Modulatory actions of the corticotrophin releasing factor binding protein. Ann. N. Y. Acad. Sci. 780:81-95; 1996.
6. Behan, D. P.; Fischer, W. H.; Park. M.; Potter, E.; Lowry, P. J.; Sutton, S.; Parkes, D.; Vale, W. W. Purification of three CRF-binding protein subtypes from sheep brain. Society for Neuroscience, Washington DC 19:414; 1993.
7. Behan, D. P.; Heinrichs, S. C.; Tronosco, J. C.; Liu, X-J.; Kawas, C. H.; Ling, N.; De Souza, E. B. Displacement of corticotrophin releasing factor from its binding protein as a possible treatment for Alzheimer's disease. Nature (London). 378:284-287; 1995.
8. Behan, D. P.; Linton E. A.; Lowry, P. J. The isolation of the plasma corticotrophin releasing factor binding protein. J. Endocrinol. 122:23-31; 1989.
9. Behan, D. P.; Maciejewski, D.; Chalmers, D.; De Souza, E. B. Corticotropin-releasing factor binding protein (CRF-BP) is expressed in neuronal and astrocytic cells. Brain Res. 689:259-264; 1995.
10. Behan, D. P.; Potter, E.; Sutton, S.; Fischer, W.; Lowry, P. J.; Vale, W. W. Corticotropin-releasing factor binding protein: a putative peripheral and central modulator of the CRF family of neuropeptides. CRF and Cytokines. Ann. N. Y. Acad. Sci. 69:71-78;1993.
11. Behan, D. P.; Potter, E. A.; Lewis, K. A.; Jenkins, N. A.; Copeland, N.; Lowry, P. J.; Vale W. W. Cloning and structure of the human CRF-binding protein gene. Genomics. 16:63-68; 1993.
12. Brenner, S. The molecular evolution of genes and proteins: a tale of two serines. Nature (London). 334:528-530; 1988.
13. Britton, K. T.; Lee, G.; Vale, W.; Rivier, J.; Koob G. Corticotrophin releasing factor (CRF) receptor antagonist blocks the activating and 'anxiogenic' actions of CRF in the rat. Brain Res. 369:303-306; 1986.
14. Buckinham, J. C.; Cowell, A.-M.; Gillies, G. E.; Herbison, A. E.; Steel J. H. The neuroendocrine system: anatomy, physiology and responses to stress. In: Buckinham, J.C.; Gillies, G.E.; Cowell, A.-M.; eds. Stress, stress hormones and the immune system. Chichester, UK: John Wiley & Sons; 1997.
15. Cambell, E. A.; Linton, E. A.; Wolfe, C. D. A.; Scraggs, P. R.; Jones, M. T.; Lowry PJ. Plasma corticotrophin releasing factor concentrations during pregnancy and parturition. J. Clin. Endocrinol. Metab. 64:1054-1059; 1987.
16. Chalmers, D.; Lovenberg, T.; Grigoriadis, D.; Behan, D.; De Souza, E. Corticotrophin releasing factor receptors: from molecular biology to drug design. Trends Pharmacol. Sci. 17:116-172; 1996.
17. Chang, C.; Pearse, R.; O'Connell, P.; Rosenfeld, M.; Hughes, H. Identification of a seven transmembrane helix receptor for corticotrophin releasing factor and sauvagine in mammalian brain. Neuron. 11:1187-1195; 1993.
18. Chatterjee, P. K.; Flint, S. J. Adenovirus type 2 endopeptidase: an unusual phosphoprotein enzyme matured by autocatalysis. Proc. Natl. Acad. Sci. USA. 84:714-718; 1987.
19. Chen, R.; Lewis, K.; Perrin, M.; Vale, W. Expression cloning of a human corticotrophin releasing factor receptor. Proc. Natl. Acad. Sci. USA. 90:8967-8971; 1993.
20. Chikanza, I. C.; Petrou, P.; Chrousos, G. P.; Kingsley, G.; Panayi, G. Defective hypothalamic response to immune/ inflammatory stimuli in patients with rheumatoid arthritis. Arthritis Rheum. 35:1281-1288; 1992.
21. Conlon, J.; Arnold-Reed, D.; Balment, R. Urotensin-1 and its N-terminal flanking peptide from the flounder, Platichthys flesus. Peptides. 11:891-895; 1990.
22. Conover, C. A. Potentiation of insulin-like growth factor (IGF) action by IGF-binding protein-3: studies of underlying mechanisms. Endocrinology. 130:3191-3199; 1992.
23. Cortright, D. N.; Gossens, K. A.; Shonee Lesh, J.; Seaholtz, A. F. Isolation and characterisation of the rat corticotrophin releasing hormone (CRH)-binding protein gene: transcriptional regulation by cyclic adenosine monophosphate and CRH. Endocrinology. 138:2098-2108; 1997.
24. Coverley, J. A.; Baxter, R. C. Regulation of insulin-like growth factor (IGF)-binding protein-3 phosphorylation by IGF-1. Endocrinology. 136:5778-5781; 1995.
25. Crofford, L. J.; Sano, H.; Karalis, K.; Friedman, T. C.; Epps, H. R.; Remmers, E. F.; Mathern, P.; Chrousos, G. P.; Wilder, R. L. Corticotrophin releasing hormone in synovial fluids and tissues of patients with rheumatoid arthritis and osteoarthritis. J. Immunol. 151:1-10; 1993.
26. Crofford, L. J.; Sano, H.; Karalis, K.; Webster, E. L.; Goldmuntz, E. A.; Chrousos, G. P.; Wilder, R. L. Local secretion of corticotrophin releasing hormone in the joints of Lewis rats with inflammatory arthritis and patients with rheumatoid arthritis. J. Clin. Invest. 90:2555-2564; 1992.
27. David, J.; Woods, R.; Kennedy, K.; Behan, D.; Potter, E.; Vale, W.; Lowry, P. J. Corticotropin releasing factor binding protein in inflammatory arthritis. Br. J. Rheumatol. 323(Suppl):2.13; 1993.
28. Donaldson, C.; Sutton, S.; Perrin, M.; Corrigan, A.; Lewis, K.; Rivier, J.; Vaughan, J.; Vale, W. Cloning and characterisation of human urocortin. Endocrinology. 137:2167-2170; 1996.
29. Ekins, R. P. The free hormone concept. In: Henneman, G.; ed. Thyroid hormone metabolism. New York: Marcell Decker; 1985:77.
30. Ekins, R. P.; Edwards, P. R. Plasma protein-mediated transport of steroid and thyroid hormones - A critique. Ann. N. Y. Acad. Sci. 538:193-203; 1988.
31. Fisher, W.; Behan, D. P.; Park, M.; Potter, E.; Lowry, P. J.; Vale, W. W. Assignment of disulphide bonds in corticotrophin releasing factor-binding protein. J. Biol. Chem. 296: 4313-4316; 1994.
32. Fowlkes, J.; Freemark, M. Evidence for a novel insulin-like growth factor (IGF) dependent protease regulating IGF binding protein-4 in dermal fibroblasts. Endocrinology. 131:2071-2076; 1992.
33. Fowlkes, J. L.; Suzuki, K.; Nagase, H.; Thrailkill, K. M. Proteolysis of insulin-like growth factor binding protein-3 during rat pregnancy: a role for matrix metalloproteinases. Endocrinology. 135:2810-2813; 1994.
34. Fowlkes, J. L.; Thrailkill, K. M.; George-Nascimento, C.; Rosenberg, C. K.; Serra, D. M. Heparin-binding, highly basic regions within the thyroglobulin type-1 repeat of insulin-like growth factor (IGF)-binding proteins (IGFBPs) -3, -5, and -6 inhibit IGFBP-4 degradation. Endocrinology. 138:2280-2285; 1997.
35. Fujita, T.; Shibuya, H.; Hotta, H.; Yamanishi, K.; Taniguchi, T. Interferon-b gene regulation: tandemly repeated sequences of a synthetic 6bp oligomer function as a virus-inducible enhancer. Cell. 49:357-367; 1987.
36. Grimes, R. W.; Hammond, J. M. Proteolytic cleavage of insulin-like growth factor (IGF)-binding protein-3 by porcine ovarian granulosa cells: regulation by IGF-1. Endocrinology. 134:337-343; 1994.
37. Grino, M.; Chrousos, GP.; Margioris, A. N. The corticotropin releasing hormone gene is expressed in human placenta. Biochem. Biophys. Res. Commun. 148:1208-1214; 1987.
38. Gulyas, J.; Rivier, C.; Perrin, M.; Koeber, S. C.; Sutton, S.; Corrigan, A.; Lahrichi, S. L.; Craig, A. G.; Vale, W.; Rivier, J. Potent, structurally constrained agonists and competitive antagonists of corticotrophin releasing factor. Proc. Natl. Acad. Sci. USA. 92:10575-10579;1995.
39. Heinrichs, S. C.; Lapsansky, J.; Behan, D. P.; Chan, R. K. W.; Sawchenko, P. E.; Lorang, M.; Ling, N.; Vale, W. W.; DeSouza, E. B. Corticotropin-releasing factor-binding protein ligand inhibitor blunts excessive weight gain in genetically obese Zucker rats and rats during nicotine with-drawal. Proc. Natl. Acad. Sci. USA. 93:15475-15480; 1996.
40. Heinrichs, S. C.; Vale, E. A.; Lapsansky, J.; Behan, D. P.; McClure, L. V.; Ling, N.; DeSouza, E. B.; Schulteis, G. Enhancement of performance in multiple learning tasks by corticotropin-releasing factor-binding protein ligand inhibitors. Peptides. 18:711-717; 1997.
41. Hench, P. S. The ameliorating effect of pregnancy on chronic atropic (infectious rheumatoid) arthritis and intermittent hydrarthrosis. Proc. Staff Meet. Mayo Clinic. 13:161; 1938.
42. Holly, J. M. P.; Claffey, E. C. P.; Cwyfan-Hughes, S. C.; Frost, V. J.; Yateman, M. E. Proteases acting on IGF-BPs; their occurrence and physiological significance. Growth Regul. 3:88-91; 1993.
43. Ichikawa, T.; McMaster, D.; Lederis, K. Isolation and amino acid sequence of urotensin-1, a vasoactive and ACTH-releasing neuropeptide, from the carp (Cyprinus carpio) urophysis. Peptides. 3:859-867; 1982.
44. Irwin, M. Brain corticotrophin releasing hormone- and interleukin 1b induced suppression of specific antibody production. Endocrinology. 133:1352-1360; 1993.
45. Jones, J. I.; D'Ercole, A. J.; Camacho-Hubner, C.; Clemmons, D. R. Phosphorylation of insulin-like growth factor (IGF)-binding protein-1 in cell culture and in vivo: effects on affinity for IGF-1. Proc. Natl. Acad. Sci. USA. 88:7481-7485; 1991.
46. Jordan, A. D.; Kordik, C. P.; Reitz, A. B.; Sanfillipo, P. J. Novel Anxiolytic Agents-1994, to present. Expert Opinion On Therapeutic Patients 6:1047-1060; 1996.
47. Kelley, K. M.; Oh, Y.; Gargosky, S. E.; Gucev, Z.; Matsumoto, T.; Hwa, V.; Ng, L.; Simpson, D. M.; Rosenfeld, R. G. Insulin-like growth factor- binding proteins (IGF-BPs) and their regulatory dynamics. Int. J. Biochem. Cell Biol. 28: 619-637; 1996.
48. Kemp, C. F.; Woods, R. J.; Totty, N.; Lowry, P. J. Proteolytic cleavage of the recombinant corticotrophin-releasing factor-binding protein. Proc. British NeuroEndocrine Group. PC34; 1996.
49. Kemp, C. F.; Woods, R. J.; Totty, N.; Sumner, I. G.; Lowry, P. J. An investigation into the physicochemical properties and post-translational modifications of the corticotrophinreleasing factor-binding protein. J. Endocrinol. 152 (Suppl): P159; 1997.
50. Kishimoto, T.; Pearse, R.; Lin, C.; Rosenfeld, G. A sauvagine/corticotrophin releasing factor receptor expressed in heart and skeletal muscle. Proc. Natl. Acad. Sci. USA. 92:1108-1112; 1995.
51. Lederis, K.; Letter, A.; McMaster, D.; Moore, G. Complete amino acid seaquake of urotensin-1, a hypotensive and corticotrophin releasing neuropeptide from Catostomus. Science (Washington DC). 218:162-164; 1982.
52. Lee, J. J.; Ekker, S. C.; von Kessler, D. P.; Porter, J. A.; Sun, B. I.; Beachy, P. A. Autoproteolysis in hedgehog protein biogenesis. Science (Washington DC). 266:1528-1537; 1994.
53. Leornado, J. M.; Baltimore, D. NF-kB: a pleotrophic mediator of inducible and tissue-specific gene control. Cell. 58: 227-229; 1989.
54. Liaw, C.; Lovenberg, T.; Barry, G.; Oltersdorf, T.; Grigoriadis, D.; DeSouza, E. Cloning and characterisation of the human CRH2 receptor cDNA. Endocrinology. 137:72-77; 1995.
55. Linton, E. A.;Behan, D. P.; Saphier, P. W.; Lowry, P. J. Corticotropin-releasing hormone binding protein: reduction in the ACTH-releasing activity of placental but not hypothalamic CRF. J. Clin. Endocrinol. Metab. 70:1574-1580; 1990.
56. Linton, E. A.; Lowry, P. J. A large molecular weight carrier for CRF-41 in human plasma. J. Endocrinol. 111(suppl.): P150; 1986.
57. Linton, E. A.; Perkins, A. V.; Woods, R. J.; Eben, F.; Wolfe, C. D. A.; Behan, D. P.; Potter, E.; Vale, W. W.; Lowry, P. J. Corticotropin releasing hormone-binding protein (CRH-BP): plasma levels decrease during the third trimester of normal pregnancy. J. Clin. Endocrinol. Metab. 76:260-262; 1993.
58. Linton, E. A.; Wolfe, C. D. A.; Behan, D. P.; Lowry, P. J. A specific carrier substance for human corticotrophin releasing factor in late gestational maternal plasma that could mask its ACTH releasing activity. Clin. Endocrinol. (Oxf). 28:315-324; 1988.
59. Lovenberg, T.; Liaw, C.; Grigoriadis, D.; Clevenger, W.; Chalmers, D.; DeSouza, E.; Oltersdorf. Cloning and characterisation of a functionally distinct corticotrophin releasing factor receptor subtype from rat brain. Proc. Natl. Acad. Sci. USA. 92:836-840; 1995.
60. Lowry, P.; Koerber, S.; Woods, R.; Baigent, S.; Sutton, S.; Behan, D.; Vale, W.; Rivier, J. Nature of ligand affinity and dimerisation of corticotrophin-releasing factor-binding protein may be detected by circular dichroism. J. Mol. Endocrinol. 16:39-44; 1994.
61. Mackiejewski, D.; Crowe, P. D.; DeSouza, E. B.; Behan, D. P. Regulation of corticotrophin-releasing factor-binding protein expression in cultured astrocytes. J. Pharmacol. Exp. Ther. 278:455-461; 1996.
62. McGillis, J.; Park, A.; Rubin-Fletter, P.; Turek, C.; Dallman, M.; Payan, D. Stimulation of rat B-lymphocyte proliferation by corticotropin-releasing factor. J. Neurosci. Res. 23:346-352; 1989.
63. Mclean, M.; Bisits, A.; Davies, J.; Woods, R.; Lowry, P.; Smith, R. A placental clock controlling the length of human pregnancy. Nat. Med. 1:460-463; 1995.
64. McMaster, D.; River, J.; Lederis, K. Isolation amino acid sequence and synthesis of urotensin-1 from Hippoglossoides elassodon. In: Shiba, T.; Sakakibara, S.; eds. Peptide chemistry. Osaka: Protein Research foundation; 1987:145-148.
65. Mendel, C. M. Free hormone hypothesis. Endocr. Rev. 10: 232-275; 1989.
66. Morell, A. G.; Gregoriadis, G.; Scheinberg, I. H.; Hickman, J.; Ashwell, G. The role of sialic acid in determining the survival of glycoproteins in the circulation. J. Biol. Chem. 246:1461-1467; 1971.
67. Motecucchi, P.; Henschen, A. Amino acid composition and sequence analysis of sauvagine: a new active peptide from methanol extracts of the South American frog, Phyllomedusa sauvegei. Int. J. Peptide Protein Res. 18:113-120; 1981.
68. Motecucchi, P.; Henschen, A.; Erspamer, V. Isolation and amino acid composition of sauvagine: an active polypeptide from methanol extracts of the South American frog, Phyllomedusa sauvegei. Int. J. Peptide Protein Res. 16:191-199; 1980.
69. Myers, S. E.; Chung, P. T.; Handwerger, S.; Chernausek, S. D. Insulin like growth factor-1 (IGF-1) enhanced proteolysis of IGF binding protein-4 in conditioned media from primary cultures of human decidua: independence from IGF receptor binding. Endocrinology. 133:1525-1531; 1994.
70. Nealy, E. R.; Rosenfeld, R. G. Insulin -like growth factors (IGFs) reduce IGF binding protein-4 (IGFBP-4) concentration and stimulate IGFBP-3 independently of IGF receptors in human fibroblasts and epidermal cells. Endocrinology. 130:985-993; 1992.
71. Nishimura, E.; Billestrup, N.; Perrin, M.; Vale, W. Identification of a pituitary corticotrophin releasing factor binding protein by chemical cross-linking. J. Biol. Chem. 262:12893-12896; 1987.
72. Oh, Y.; Gucev, Z.; Ng, L.; Muller, H. L.; Rosenfeld, R. G. Anti-proliferative actions of insulin-like growth factor (IGF)-binding protein-3 in human breast cancer cells. Prog. Growth Factor Res. 6:503-512; 1995.
73. Orth, D. N.; Mount, C. D. A specific high affinity binding protein for human corticotrophin releasing factor in normal human plasma. Biochem. Biophys. Res. Commun. 143:411-417; 1987.
74. Peckham, W. D.; Yamaji, T.; Dierschke, D. J.; Knobil, E. Gonadal Function and the biologic and physico-chemical properties of follicle stimulating hormone. Endocrinology. 92:1660-1666; 1973.
75. Perkins, A. V.; Eben, F.; Wolfe, C. D.; Schulte, H. M.; Linton, E. A. Plasma measurements of corticotrophin-releasing hormone-binding protein in normal and abnormal human pregnancy. J. Endocrinol. 138:149-57;1993.
76. Perrin, M.; Donaldson, C.; Chen, R.; Lewis, K.; Vale, W. Cloning and functional expression of a rat brain corticotrophin releasing factor receptor. Endocrinology. 133:3058-30611; 1993.
77. Perrin, M. H.; Haas, Y.; Rivier, J. E.; Vale, W. W. Corticotrophin releasing factor binding to the anterior pituitary receptor is modulated by divalent cations and guanyl nucleotides. Endocrinology. 118:1171-1179; 1986.
78. Petraglia, F.; Potter, E.; Cameron, V.; Sutton, S.; Behan, D. P.; Woods, R. J.; Sawchenko, P. E.; Lowry, P. J.; Vale, W. W. Corticotropin-releasing factor-binding protein is produced by human placenta, fetal membranes and maternal decidua. J. Clin. Endocrinol. Metab. 77:919-924; 1993.
79. Poliak, S.; Mor, F.; Conlon, P.; Wong, T.; Ling, N.; Rivier, J.; Vale, W.; Steinman, L. Stress and autoimmunity: the neuropeptides corticotropin-releasing factor and urocortin suppress encephalomyelitis via effects on both the hypothalamic-pituitary-adrenal axis and the immune system. J. Immunol. 158:5751-5756; 1997.
80. Potter, E.; Behan, D.; Lowry, P.; Vale, W. HPA axis can alter the expression of corticotrophin releasing factor-binding protein in the pituitary. 75th Annual meeting of the Endocrine Society; Abstract 1675; 1993.
81. Potter, E.; Behan, D. P.; Fischer, W. H.; Linton, E. A.; Lowry P. J.; Vale, W. W. Cloning and characterization of the cDNAs for human and rat corticotropin releasing factor-binding proteins. Nature (London). 349:423-426; 1991.
82. Potter, E.; Behan, D. P.; Linton, E. A.; Lowry, P. J.; Sawchenko, P. E.; Vale, W. W. The central distribution of a corticotropin-releasing factor-binding protein predicts multiple sites and modes of interaction with CRF. Proc. Natl. Acad. Sci. USA. 89:4192-4196; 1992.
83. Potter, E.; Sutton, S.; Donaldson, C.; Chen, R.; Perrin, M.; Lewis, K.; Sawchenko, P.; Vale, W. Distribution of corticotrophin releasing factor receptor mRNA expression in the rat brain and pituitary. Proc. Natl. Acad. Sci. USA. 91:8777-8781; 1994.
84. Recant, L.; Riggs, D. S. Thyroid function in nephrosis. J. Clin. Invest. 31:789; 1952.
85. Rees, L. H.; Burke, C. W.; Chard, T; Evans, S. W.; Letchworth, A. T. Possible placental origin of ACTH in normal human pregnancy. Nature (London). 254:620-622; 1975.
86. Rivier, J.; Rivier, C.; Vale, W. Synthetic competitive antagonists of corticotrophin releasing factor: effect on ACTH secretion in rats. Science (Washington DC). 224:889-891; 1984.
87. Ron, D.; Brasier, A. R.; Wright, K. A.; Tate, J. E.; Habener, J. F. An inducible 50-kDa NF-kB-like protein and constitu-tive protein that both bind the acute phase response element of the angiotensin gene. Mol. Cell Biol. 10:1023-1032; 1990.
88. Rosendale, B. E.; Jarrett, D. B.; Robinson, A. G. Identification of a corticotrophin releasing factor binding protein in the plasma membrane of AtT-20 mouse pituitary tumor cells and its regulation by dexamethasone. Endocrinology. 120:2357-2366; 1987.
89. Sasai, Y.; De Robertis, E. M. Ectodermal patterning in vertebrate embryos. Dev. Biol. 182:5-20; 1997.
90. Schwatz, U.; Volger, H.; Schneller, H.; Moltz, L.; Hammerstein, J. Effect of various replacement oestrogens on hepatic transcortin synthesis in climacteric women. Acta Endocrinol. 102:103-107; 1983.
91. Shibasaki, T.; Odagiri, E.; Shizume, K.; Ling, N. Corticotropin-releasing factor like activity in human placental extract. J. Clin. Endocrinol. Metab. 55:384-386; 1982.
92. Singh, V.; Fundenberg, H. Binding of [125 I] corticotrophin releasing factor to blood immunocytes and its reduction in Alzheimer's disease. Immunol. Lett. 18:5-8; 1988.
93. Singh, V. K. Stimulatory effect of corticotropin-releasing neurohormone on human lymphocyte proliferation and IL-2 receptor expression. J. Neuroimmunol. 23:256-262; 1989.
94. Singh, V. K.; Leu, C. S. J. Enhancing effect of corticotropin-releasing neurohormone on the production of IL-1 and IL-2. Neurosci. Lett. 120:151-154; 1990.
95. Spina, M.; Merlo-Pich, E.; Chan, R.; Basso, A.; Rivier, J.; Vale, W.; Koob, G. Appetite suppressing effects of urocortin, a CRF-related peptide. Science (Washington DC). 273:1561-1564; 1996.
96. Suda, T.; Iwashita, M.; Towaza, F.; Usiyama, T.; Tomori, N.; Sumitomo, T.; Nakagamo, Y.; Demura, H.; Shizume, K. Characterisation of corticotrophin releasing factor binding protein in human plasma by chemical cross linking and its binding during pregnancy. J. Clin. Endocrinol. Metab. 67: 1278-1283; 1988.
97. Sutton, S.; Behan, D.; Lahrichi, S.; Kaiser, R.; Corrigan, A.; Lowry, P.; Potter, E.; Perrin, M.; Rivier, J.; Vale W. Ligand requirements for the corticotrophin releasing factor binding protein. Endocrinology. 136:1097-1102; 1995.
98. Thrailkill, K. M.; Quarles, L. D.; Nagase, H.; Suzuki, K.; Serra, D. M.; Fowlkes, J. L. Characterisation of insulin-like growth factor-binding protein 5-degrading proteases produced throughout murine osteoblast differentiation. Endocrinology. 136:3527-3533; 1995.
99. Valdenaire, O.; Giller, T.; Breu, V.; Gottowik, J.; Kilpatrick, G. A new functional isoform of the human CRF2 receptor for corticotropin-releasing factor. Biochim. Biophys. Acta. 1352:129-32;1997.
100. Vale, W.; Spiess, J.; Rivier, C.; Rivier, J. Characterization of a 41-residue ovine hypothalamic peptide that stimulate secretion of corticotropin and β-endorphin. Science (Washington DC). 213:1394-1397; 1981.
101. Vaughan, J.; Donaldson, C.; Bittencourt, J.; Perrin, M.; Lewis, K.; Sutton, S.; Chan, R.; Turnbull, A.; Lovejoy, D.; Rivier, C.; Rivier, J.; Sawchenko, P. E.; Vale, W. Urocortin, a mammalian neuropeptide related to fish urotensin-1 and corticotrophin releasing factor. Nature (London). 378:287-292; 1995.
102. Webster, E. L.; DeSouza, E. B. Corticotrophin releasing factor receptors in the mouse spleen: identification, autoradiographic localisation and regulation by divalent cations and guanyl nucleotides. Endocrinology. 122:609-618; 1988.
103. Wong, M.; Licinio, J.; Pasternak, K.; Gold P. Localisation of corticotrophin releasing factor receptor mRNA expression in adult rat brain by in situ hybridisation histochemistry. Endocrinology. 135:2275-2278; 1994.
104. Wong, M. L.; al-Shekhlee, A.; Bongiorno, P. B.; Esposito, A.; Khatri, P.; Sternberg, E. M.; Gold, P. W.; Licinio, J. Localization of urocortin messenger RNA in rat brain and pituitary. Mol. Psychiatry. 1:307-312; 1996.
105. Woods, R.; David, J.; Baigent, S.; Gibbins, J.; Lowry, P. Elevated levels of corticotrophin releasing factor binding protein in the blood of patients suffering from arthritis and septacaemia and the presence of novel ligands in synovial fluid. Br. J. Rheumatol. 35:120-124; 1996.
106. Woods, R.; Kennedy, K.; Gibbins, J.; Behan, D.; Potter, E.; Vale, W.; Lowry, P. Corticotropin releasing factor binding protein dimerizes after association with ligand. Endocrinology. 135:768-773;1993.
107. Woods, R. J.; Grossman, A.; Saphier, P.; Kennedy, K.; Ur, E.; Behan, D.; Potter, E.; Vale, W.; Lowry, P. J. Association of h-CRH to its binding protein in blood may trigger clearance of the complex. J. Clin. Endocrinol. Metab. 78:73-76; 1994.
108. Woods, R. J.; Kemp, C. F.; David, J.; Lowry, P. J. Heterogeneity of the human corticotrophin-releasing factor-binding protein. J. Clin. Endocrinol. Metab. 82:1566-1571; 1997.
109. Wynn, P. C.; Aguilera, G.; Morrell, J.; Catt, K. J. Properties and regulation of high affinity pituitary receptors for corticotrophin releasing factor. Biochem. Biophys. Res. Commun. 110:602-608; 1983.